How to Protect the Vulnerable Groups in Drug Clinical Trials / 中国医学伦理学
Chinese Medical Ethics
;
(6): 572-575, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-619277
ABSTRACT
Objective:
To find a better way to protect the security and interests of vulnerable groups by exploring the problem of protecting the vulnerable groups in drug clinical trial from the perspectives of ethics committees,organization and researchers.Methods:
According to the relevant literature and the actual situation of the hospital,this paper analyzed the security issues of vulnerable groups comprehensively.Results:
Only the ethics committees,organization and researchers work together,can it protect the security and interests of vulnerable groups to the greatest extents.Conclusion:
Further research on the security of vulnerable groups not only promotes the development of human health,but also plays a decisive role in improving the protection of subjects in drug clinical trial.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Medical Ethics
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS